Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Lemon Juice and Apple Cider Vinegar on Postprandial Blood Glucose and Satiety in Healthy Individuals

26 aprile 2026 aggiornato da: Ezgi Toptaş Biyikli, Alanya Alaaddin Keykubat University

The Effect of Lemon Juice and Apple Cider Vinegar on Postprandial Blood Glucose and Satiety in Healthy Individuals

This clinical study aims to examine how acidic drinks (lemon juice and apple cider vinegar) affect blood sugar when consumed with a starchy food. The study focuses on healthy individuals and aims to understand whether these drinks can slow the rise in blood sugar after meals and affect feelings of fullness.

The main questions this study aims to answer are:

Do lemon juice or apple cider vinegar lower the rise in blood sugar after a meal? Do these drinks increase feelings of fullness? Do different amounts change their effects?

Researchers will compare lemon juice and apple cider vinegar to see which one is more effective.

Participants will:

Consume white bread in the morning on an empty stomach with one of the following drinks:

Water only Water with lemon juice (50 g or 100 g) Water with apple cider vinegar (10 g or 20 g) Have a one-week break between each test. Have their blood sugar measured at regular intervals for 3 hours after eating. Report their level of fullness using a simple scale.

This study explores whether simple and practical dietary choices can help manage blood sugar levels. The findings may support new, easy-to-apply nutrition strategies for managing diabetes and weight.

Panoramica dello studio

Descrizione dettagliata

Glycemic response plays an important role in the prevention and management of metabolic conditions such as diabetes and obesity. Different foods can cause rapid or slow increases in blood sugar levels. One factor that may influence this response is the acidity of foods. Acidic components may slow starch digestion and delay the rise in blood glucose by affecting digestive enzymes and gastric emptying. However, there are limited studies examining how the acidity of meals influences glycemic response in practical, real-life conditions.

This study is designed to investigate the effects of consuming acidic beverages, specifically lemon juice and apple cider vinegar, together with a starch-rich food. The study will compare their effects on post-meal blood glucose levels and feelings of fullness in healthy individuals. Different amounts of these acidic components will also be evaluated to understand dose-related effects.

Participants will consume standardized meals under controlled conditions, and their blood glucose response and satiety levels will be monitored over time. The study follows a comparative approach to assess the relative effectiveness of each intervention.

The findings of this study may help identify simple and practical dietary strategies to support better blood sugar control. As lemon juice and vinegar are widely available and easy to include in daily meals, the results may offer accessible approaches for improving dietary habits and supporting metabolic health.

Tipo di studio

Interventistico

Iscrizione (Stimato)

15

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Antalya
      • Alanya, Antalya, Turchia (Türkiye), 07400
        • Reclutamento
        • Alanya Alaaddin Keykubat University
        • Contatto:
          • Alanya Alaaddin Keykubat University
          • Numero di telefono: +90 242 +90 242 510 60 60
          • Email: alku@alanya.edu.tr

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Descrizione

Inclusion Criteria:

  • Healthy male and female volunteers aged 18-35 years
  • Body Mass Index (BMI) between 18.5 and 25.0 kg/m²
  • Willingness to provide written informed consent
  • Ability to comply with study procedures and fasting requirements
  • No history of chronic metabolic, gastrointestinal, or endocrine diseases

Exclusion Criteria:

  • Presence of any chronic disease (e.g., diabetes mellitus, cardiovascular disease, gastrointestinal disorders)
  • Food allergies or intolerances to study foods (white bread, lemon juice, apple cider vinegar)
  • BMI <18.5 or >25.0 kg/m²
  • Regular participation in high-intensity physical activity (≥5 days/week)
  • Current or recent (past 3 months) smoking or smoking cessation
  • Use of any medication or supplements affecting glucose metabolism
  • History of eating disorders
  • Pregnancy, lactation, or menopause
  • Female participants currently in menstruation period (testing will be postponed during menstruation days)
  • Alcohol consumption within 24 hours prior to testing days
  • Caffeine intake or major dietary changes on the day before testing

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Control (Water + White Bread)
Participants consume white bread together with plain water only. This arm serves as the control condition to evaluate postprandial blood glucose response without any acidic additive.
Participants will consume 100 g of white bread together with plain water (no acidic additive). This condition serves as the control arm for assessing baseline postprandial glycemic response and satiety. Capillary blood glucose will be measured at baseline and at multiple time points up to 180 minutes following consumption. Satiety and appetite sensations will be assessed using a 100-mm visual analog scale (VAS).
Sperimentale: Lemon Juice 50 g
Participants consume white bread together with water containing 50 g lemon juice. This arm evaluates the effect of low-dose lemon juice on postprandial blood glucose response and satiety.
Participants will consume 100 g of white bread together with 50 g of lemon juice diluted in water. This intervention is designed to evaluate the effect of a low-dose acidic beverage (citric acid source) on postprandial blood glucose response and satiety. Capillary blood glucose levels will be measured at predefined time points up to 180 minutes, and subjective appetite sensations will be assessed using a 100-mm VAS.
Sperimentale: Lemon Juice 100 g
Participants consume white bread together with water containing 100 g lemon juice. This arm evaluates the dose-dependent effect of lemon juice on postprandial blood glucose response and satiety.
Participants will consume 100 g of white bread together with 100 g of lemon juice diluted in water. This condition evaluates the dose-dependent effect of citric acid intake on postprandial glycemic response, glucose peak, and satiety. Serial capillary blood glucose measurements and VAS-based appetite assessments will be conducted over a 180-minute postprandial period.
Sperimentale: Apple Cider Vinegar 10 g
Participants consume white bread together with water containing 10 g apple cider vinegar. This arm evaluates the effect of low-dose apple cider vinegar on postprandial blood glucose response and satiety.
Participants will consume 100 g of white bread together with 10 g of apple cider vinegar diluted in water. This intervention aims to assess the effect of a low-dose acetic acid source on postprandial glucose regulation and satiety. Capillary blood glucose will be measured at multiple time points for 180 minutes, and subjective appetite ratings will be recorded using a visual analog scale.
Sperimentale: Apple Cider Vinegar 20 g
Participants consume white bread together with water containing 20 g apple cider vinegar. This arm evaluates the effect of higher-dose apple cider vinegar on postprandial blood glucose response and satiety.
Participants will consume 100 g of white bread together with 20 g of apple cider vinegar diluted in water. This intervention evaluates the potential dose-response effect of acetic acid on postprandial glycemic control, including glucose peak, incremental glucose response, and satiety perception over a 180-minute period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postprandial Blood Glucose (mg/dL)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day (with 1-week washout between interventions)
Capillary blood glucose levels will be measured at baseline (0 min) and at 15, 30, 45, 60, 90, 120, 150, and 180 minutes after consumption of test meals. Measurements will be performed in duplicate and mean values will be used.
Baseline (0 min) to 180 minutes postprandial on each test day (with 1-week washout between interventions)
Incremental Area Under the Curve (iAUC)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day
Incremental area under the curve (iAUC) for postprandial blood glucose will be calculated based on capillary glucose measurements over 180 minutes.
Baseline (0 min) to 180 minutes postprandial on each test day
Total Area Under the Curve (AUC)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day
Total area under the curve (AUC) for postprandial blood glucose will be calculated using capillary glucose measurements over 180 minutes.
Baseline (0 min) to 180 minutes postprandial on each test day
Peak Blood Glucose Level (mg/dL)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day
Peak postprandial blood glucose level will be determined from capillary glucose measurements over the 180-minute period.
Baseline (0 min) to 180 minutes postprandial on each test day

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Subjective Appetite Score (VAS, mm)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day
Subjective appetite sensations (hunger, satiety, fullness, prospective food consumption, and desire for sweet foods) will be assessed using a 100-mm Visual Analog Scale (VAS) at baseline and at 15, 30, 45, 60, 90, 120, 150, and 180 minutes postprandially.
Baseline (0 min) to 180 minutes postprandial on each test day
Time to Peak Glucose (minutes)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day
Time to reach peak postprandial blood glucose will be calculated from capillary glucose measurements.
Baseline (0 min) to 180 minutes postprandial on each test day
Rate of Glucose Increase (mg/dL/min)
Lasso di tempo: Baseline (0 min) to 180 minutes postprandial on each test day
Rate of increase in postprandial blood glucose will be calculated based on capillary glucose measurements.
Baseline (0 min) to 180 minutes postprandial on each test day

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Collegamenti utili

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 maggio 2026

Completamento primario (Stimato)

1 luglio 2026

Completamento dello studio (Stimato)

1 luglio 2026

Date di iscrizione allo studio

Primo inviato

21 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

26 aprile 2026

Primo Inserito (Effettivo)

4 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

4 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

26 aprile 2026

Ultimo verificato

1 aprile 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 10354421-2025/09-10

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi